Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on November 24, 2003

Circulation. 2003
Published online before print November 24, 2003, doi: 10.1161/01.CIR.0000097068.49080.A0
A more recent version of this article appeared on December 2, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/22/2819    most recent
01.CIR.0000097068.49080.A0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kingston, P. A.
Right arrow Articles by Heagerty, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kingston, P. A.
Right arrow Articles by Heagerty, A. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Angioplasty
Related Collections
Right arrow Gene therapy
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Restenosis
Right arrow Growth factors/cytokines

Submitted on April 18, 2002
Revised on June 23, 2003
Accepted on August 1, 2003

Adenovirus-Mediated Gene Transfer of Transforming Growth Factor-{beta}3, but Not Transforming Growth Factor-{beta}1, Inhibits Constrictive Remodeling and Reduces Luminal Loss After Coronary Angioplasty

Paul A. Kingston MRCP, PhD*, Sanjay Sinha MRCP, PhD, Clare E. Appleby BA, MRCP, Anne David PhD, Thomas Verakis MSc, Maria G. Castro PhD, Pedro R. Lowenstein MD, PhD, and Anthony M. Heagerty FRCP, MD

From the Vascular Gene Therapy Unit, University of Manchester (P.A.K., A.D., C.E.A., T.V., M.G.C., P.R.L.), and Department of Medicine, Manchester Royal Infirmary (S.S., A.M.H.), Manchester, UK. Drs Castro and Lowenstein are now with the Gene Therapeutics Research Institute, Cedars Sinai Medical Center, Los Angeles, Calif.

* To whom correspondence should be addressed. E-mail: paul.a.kingston{at}man.ac.uk.

Background--Extracellular matrix (ECM) remodeling is central to the development of restenosis after PTCA. Substantial evidence implicates transforming growth factor-{beta}1 (TGF-{beta}1), a regulator of ECM deposition by vascular cells, in its pathogenesis. TGF-{beta}3 reduces TGF-{beta}1--induced ECM deposition in cutaneous wounds. We therefore investigated the effects of intracoronary expression of TGF-{beta}3 and TGF-{beta}1 on luminal loss after angioplasty.

Methods and Results--Porcine coronary arteries received an adenovirus expressing TGF-{beta}3, TGF-{beta}1, or lacZ ({beta}-galactosidase), or PBS only, at the site of angioplasty. Morphometric analysis 28 days after angioplasty confirmed reduced luminal loss in TGF-{beta}3 vessels (-0.65±0.10 mm2) compared with lacZ (-1.18±0.19 mm2) or PBS only (-1.19±0.17 mm2; P=0.003). Luminal loss was not reduced in TGF-{beta}1 vessels (-1.02±0.19 mm2; P=0.48). An increase in the external elastic lamina area in TGF-{beta}3-treated vessels (+0.73±0.32 mm2) contrasted with decreases in control vessels (mean, -0.53±0.17 mm2; P=0.001) and TGF-{beta}1 vessels (-0.87±0.34 mm2; P=0.003). Collagen content increased at the site of injury in TGF-{beta}3-treated vessels (26.1±14.2%) but decreased in the lacZ (-22.8±6.6%) and PBS-only (-23.4±7.0%; P=0.002) groups and was not significantly changed in TGF-{beta}1-treated vessels.

Conclusions--Expression of TGF-{beta}3 inhibits constrictive remodeling after PTCA and reduces luminal loss. This is accompanied by increased adventitial collagen, which may act as an external "scaffold" preventing vessel constriction. These findings confirm the potential of gene therapies that modify ECM remodeling for prophylaxis of restenosis.


Key words: angioplasty • gene therapy • restenosis • collagen




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Jiang, P. Yu, M. Tao, C. Fernandez, C. Ifantides, O. Moloye, G. S. Schultz, C. K. Ozaki, and S. A. Berceli
TGF-beta- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H482 - H488.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Khan, A. Agrotis, and A. Bobik
Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury
Cardiovasc Res, May 1, 2007; 74(2): 223 - 234.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. P.G. Sluijter, R. E. Verloop, W. P.C. Pulskens, E. Velema, J. M. Grimbergen, P. H. Quax, M.-J. Goumans, G. Pasterkamp, and D. P.V. de Kleijn
Involvement of furin-like proprotein convertases in the arterial response to injury
Cardiovasc Res, October 1, 2005; 68(1): 136 - 143.
[Abstract] [Full Text] [PDF]